How Long Can You Stay on HRT? What the Guidelines Actually Say

There is no fixed time limit on hormone therapy. The old rules to stop after five years, or at age 60 or 65, are out of date, and the current guidance comes down to one thing: you continue for as long as the benefits outweigh the risks for you.

If a provider once told you otherwise, that advice has not kept up with the research. We'll walk through where the old rules came from, what the guidelines actually say now, how the decision changes as you age, and what stopping is really like.

The Short Answer, and the Old Rules It Replaces

The current position of every major menopause society is that there is no set time limit on hormone therapy. You continue for as long as the benefits outweigh the risks for you, reviewed with a provider each year.

The International Menopause Society put it directly in its 2024 paper: arbitrary limits should not be placed on how long you use it. That is a real change from what many women were told, so here is the old guidance next to where things stand now.

Where the Five-year Rule Came From

The stop-at-five-years idea traces back to the Women's Health Initiative, the large study whose early results in the 2000s linked hormone therapy to breast cancer and stroke and led doctors to pull millions of women off it. Two things have changed since. The data was re-examined, and much of the risk turned out to be tied to who was studied, older women starting many years after menopause, and to the specific drugs used, an oral conjugated estrogen paired with a synthetic progestin.

The hormones most women are prescribed today are different.

We cover the modern risk picture in HRT side effects and safety, and the shift toward body-identical hormones delivered through the skin rather than as a pill is a big part of why the old blanket time limit no longer fits.

So How Long Is Right for You?

Because there is no universal number, the length of your treatment comes down to a handful of personal factors that you and your provider weigh together.

• Your symptoms, and whether they are still there. Some women find their hot flashes settle within a few years and taper off. Others have symptoms well into their sixties and seventies, and that group has the clearest reason to keep going.
• When you started. Beginning within ten years of your last period, or before 60, is the window where the balance of benefit to risk is most favorable, and it shapes how comfortably you can continue.
• Your personal and family history. A family history of osteoporosis, heart disease, or dementia can tip the decision toward longer use for the protection, while a personal history of breast cancer or clots pulls the other way.
• Your goals beyond symptoms. Bone health in particular keeps many women on longer. Certain FDA-approved estrogen products carry an approved indication for preventing postmenopausal osteoporosis, though compounded hormone therapy is not FDA-approved and carries no such indication.

For some women that adds up to a few years. For others it means staying on indefinitely. Both are legitimate, and neither is the default.

Staying on Past 60 and 65

This is where the most confusion lives, because some providers still treat 65 as an automatic stop date.

It is not. The Menopause Society states plainly that there is no evidence-based rule requiring women to stop at 65, and neither the Society nor the American College of Obstetricians and Gynecologists recommends routine discontinuation at that age.

Honesty cuts both ways, though. The long-term safety data for starting or continuing past 65 is thinner than we would like, which is exactly why the decision becomes more individual with age rather than less.

The reassuring part comes from a 2024 analysis of more than ten million women on Medicare, which found that those who continued estrogen-only therapy beyond 65 had a meaningfully lower risk of death, along with lower rates of several cancers and heart failure. The picture was more mixed for estrogen combined with a progestogen, where a small increase in breast cancer risk showed up, though that risk was reduced with lower doses and skin or vaginal delivery rather than pills.

The practical takeaway for longer-term use is the same one that runs through modern menopause care: the lowest dose that keeps you well, delivered through the skin rather than by mouth, reassessed every year.

The Comparison Women Keep Making

There is an analogy that comes up constantly in menopause communities, and it is worth sitting with.

Nobody tells a person with an underactive thyroid to take thyroid hormone for five years and then stop, or a person with diabetes to quit insulin at 65. Menopause is a hormone your body stopped making, and for many women, replacing it is a long-term proposition rather than a short course.

The comparison is not perfect, because the risk and benefit math for estrogen is its own thing and has to be weighed individually. But it captures why an arbitrary stop date never made much sense, and why the guidelines quietly dropped it.

What Happens if You Stop

If you and your provider decide to stop, here is what to expect, because it is not always what women assume.

• Your symptoms may come back. This surprises people, especially those who stop after many years. It happens because hormone therapy does not delay or pause menopause, it treats it. Untreated menopause symptoms can last a decade or more on their own, so if they return when you stop, that is the underlying menopause showing through, not a rebound the medication created.
• Tapering is commonly used, though the evidence is mixed on whether it prevents symptoms from returning. Many providers lower the dose gradually over weeks or months to ease the transition rather than stopping all at once.
• You can restart. Stopping is not a one-way door. If you come off and your quality of life drops, restarting, often at a lower dose, is a normal next step.
• Some women feel fine, or even better, off it. That is real too. This is a trial worth paying attention to rather than a decision you have to get right in advance.

Vaginal Estrogen: The Exception With No Time Limit

One form of hormone therapy sits outside this whole conversation.

Low-dose vaginal estrogen, used for vaginal dryness, irritation, and recurrent urinary infections, delivers so little hormone to the rest of the body that it is not subject to the same duration limits at all, and it can be used indefinitely. The 2025 guideline from the American Urological Association confirms that low-dose vaginal estrogen does not raise the risk of breast cancer recurrence, heart disease, dementia, or endometrial cancer, and that even women with a history of breast cancer can use it through shared decision-making with their provider.

If your main issue is local, this is often the easiest long-term answer.

If You and Your Provider Disagree

If your provider wants you to stop and you do not feel ready, you have options. The gap between the current guidelines and what some clinicians still practice is real, and plenty of women change providers rather than give up a therapy that is working. A menopause-focused provider will make this an individualized, evidence-based conversation rather than a birthday deadline.

Josie connects you with licensed providers who follow current guidance and will reassess your plan with you over time rather than hand you an expiration date.

You can see the hormone therapy Josie offers, or check whether HRT is right for you to start.

The bottom line is that how long you stay on hormone therapy is a decision you make with a provider and revisit over time, not a fixed term set the day you start. For most healthy women who begin in the window, there is no reason to stop just because a set number of years has passed or a birthday has arrived.

This article is for education and is not medical advice. Hormone therapy carries risks as well as benefits and is not right for everyone. Compounded hormone therapy is not FDA-approved, and the FDA does not review compounded medications for safety, effectiveness, or quality before marketing.